Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 972

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Open access
Duan, Tianhao, Du, Yang, Xing, Changsheng, Wang, Helen Y., Wang, Rong-Fu·2022·Frontiers in Immunology

Abstract

Innate immunity is the first defense system against invading pathogens. Toll-like receptors (TLRs) are well-defined pattern recognition receptors responsible for pathogen recognition and induction of innate immune responses. Since their discovery, TLRs have revolutionized the field of immunology by filling the gap between the initial recognition of pathogens by innate immune cells and the activation of the adaptive immune response. TLRs critically link innate immunity to adaptive immunity by regulating the activation of antigen-presenting cells and key cytokines. Furthermore, recent studies also have shown that TLR signaling can directly regulate the T cell activation, growth, differentiation, development, and function under diverse physiological conditions. This review provides an overview of TLR signaling pathways and their regulators and discusses how TLR signaling, directly and indirectly, regulates cell-mediated immunity. In addition, we also discuss how TLR signaling is critically important in the host’s defense against infectious diseases, autoimmune diseases, and cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2022.812774

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 313

  1. Takeuchi, 2010, Pattern Recognition Receptors and Inflammation, Cell, 140, 10.1016/j.cell.2010.01.022 · DOI · Paper page
  2. Akira, 2006, Pathogen Recognition and Innate Immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015 · DOI · Paper page
  3. Cai, 2014, The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling, Mol Cell, 54, 10.1016/j.molcel.2014.03.040 · DOI · Paper page
  4. Iwasaki, 2004, Toll-Like Receptor Control of the Adaptive Immune Responses, Nat Immunol, 5, 10.1038/ni1112 · DOI · Paper page
  5. Hayden, 2011, NF-kappaB in Immunobiology, Cell Res, 21, 10.1038/cr.2011.13 · DOI · Paper page
  6. Kawasaki, 2014, Toll-Like Receptor Signaling Pathways, Front Immunol, 5, 10.3389/fimmu.2014.00461 · DOI · Paper page
  7. Wang, 2012, Innate Immune Signaling and Negative Regulators in Cancer, 10.1007/978-1-4419-9914-6_6 · DOI
  8. Lemaitre, 1996, The Dorsoventral Regulatory Gene Cassette Spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults, Cell, 86, 10.1016/S0092-8674(00)80172-5 · DOI · Paper page
  9. Medzhitov, 1997, A Human Homologue of the Drosophila Toll Protein Signals Activation of Adaptive Immunity, Nature, 388, 10.1038/41131 · DOI · Paper page
  10. Kawai, 2010, The Role of Pattern-Recognition Receptors in Innate Immunity: Update on Toll-Like Receptors, Nat Immunol, 11, 10.1038/ni.1863 · DOI · Paper page
  11. Fore, 2020, TLR10 and Its Unique Anti-Inflammatory Properties and Potential Use as a Target in Therapeutics, Immune Netw, 20, 10.4110/in.2020.20.e21 · DOI
  12. Henrick, 2019, TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection, Front Immunol, 10, 10.3389/fimmu.2019.00482 · DOI
  13. Lind, 2021, Regulation of the Nucleic Acid-Sensing Toll-Like Receptors, Nat Rev Immunol, 16, 1, 10.1038/s41577-021-00577-0 · DOI · Paper page
  14. Medzhitov, 2001, Toll-Like Receptors and Innate Immunity, Nat Rev Immunol, 1, 10.1038/35100529 · DOI · Paper page
  15. Botos, 2011, The Structural Biology of Toll-Like Receptors, Structure, 19, 10.1016/j.str.2011.02.004 · DOI · Paper page
  16. McClure, 2014, TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens, Front Immunol, 5, 10.3389/fimmu.2014.00386 · DOI · Paper page
  17. Sutmuller, 2006, Toll-Like Receptors on Regulatory T Cells: Expanding Immune Regulation, Trends Immunol, 27, 10.1016/j.it.2006.06.005 · DOI · Paper page
  18. Hua, 2013, TLR Signaling in B-Cell Development and Activation, Cell Mol Immunol, 10, 10.1038/cmi.2012.61 · DOI · Paper page
  19. Bhagavan, 2011, Chapter 33 - Immunology
  20. Hoffmann, 1999, Phylogenetic Perspectives in Innate Immunity, Science, 284, 10.1126/science.284.5418.1313 · DOI · Paper page
  21. Aderem, 2000, Toll-Like Receptors in the Induction of the Innate Immune Response, Nature, 406, 10.1038/35021228 · DOI · Paper page
  22. Blasius, 2010, Intracellular Toll-Like Receptors, Immunity, 32, 10.1016/j.immuni.2010.03.012 · DOI · Paper page
  23. Latz, 2007, Ligand-Induced Conformational Changes Allosterically Activate Toll-Like Receptor 9, Nat Immunol, 8, 10.1038/ni1479 · DOI · Paper page
  24. Fitzgerald, 2001, Mal (MyD88-Adapter-Like) Is Required for Toll-Like Receptor-4 Signal Transduction, Nature, 413, 78, 10.1038/35092578 · DOI · Paper page
  25. Horng, 2001, TIRAP: An Adapter Molecule in the Toll Signaling Pathway, Nat Immunol, 2, 10.1038/ni0901-835 · DOI · Paper page
  26. Yamamoto, 2003, TRAM is Specifically Involved in the Toll-Like Receptor 4-Mediated MyD88-Independent Signaling Pathway, Nat Immunol, 4, 10.1038/ni986 · DOI · Paper page
  27. Fitzgerald, 2003, LPS-TLR4 Signaling to IRF-3/7 and NF-Kappa B Involves the Toll Adapters TRAM and TRIF, J Exp Med, 198, 10.1084/jem.20031023 · DOI · Paper page
  28. Kagan, 2008, TRAM Couples Endocytosis of Toll-Like Receptor 4 to the Induction of Interferon-Beta, Nat Immunol, 9, 10.1038/ni1569 · DOI · Paper page
  29. Rowe, 2006, The Myristoylation of TRIF-Related Adaptor Molecule Is Essential for Toll-Like Receptor 4 Signal Transduction, Proc Natl Acad Sci USA, 103, 10.1073/pnas.0510041103 · DOI · Paper page
  30. Kagan, 2006, Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-Like Receptor Signaling, Cell, 125, 10.1016/j.cell.2006.03.047 · DOI · Paper page
  31. Kagan, 2014, SMOCs: Supramolecular Organizing Centres That Control Innate Immunity, Nat Rev Immunol, 14, 10.1038/nri3757 · DOI · Paper page
  32. Motshwene, 2009, An Oligomeric Signaling Platform Formed by the Toll-Like Receptor Signal Transducers MyD88 and IRAK-4, J Biol Chem, 284, 10.1074/jbc.M109.022392 · DOI · Paper page
  33. Bonham, 2014, A Promiscuous Lipid-Binding Protein Diversifies the Subcellular Sites of Toll-Like Receptor Signal Transduction, Cell, 156, 10.1016/j.cell.2014.01.019 · DOI · Paper page
  34. Cao, 1996, IRAK: A Kinase Associated With the Interleukin-1 Receptor, Science, 271, 10.1126/science.271.5252.1128 · DOI · Paper page
  35. Li, 2002, IRAK-4: A Novel Member of the IRAK Family With the Properties of an IRAK-Kinase, Proc Natl Acad Sci USA, 99, 10.1073/pnas.082100399 · DOI · Paper page
  36. Kollewe, 2004, Sequential Autophosphorylation Steps in the Interleukin-1 Receptor-Associated Kinase-1 Regulate its Availability as an Adapter in Interleukin-1 Signaling, J Biol Chem, 279, 10.1074/jbc.M309251200 · DOI · Paper page
  37. Sun, 2016, Comprehensive RNAi-Based Screening of Human and Mouse TLR Pathways Identifies Species-Specific Preferences in Signaling Protein Use, Sci Signal, 9, 10.1126/scisignal.aab2191 · DOI
  38. Clark, 2013, Molecular Control of the NEMO Family of Ubiquitin-Binding Proteins, Nat Rev Mol Cell Biol, 14, 10.1038/nrm3644 · DOI
  39. Windheim, 2008, Interleukin-1 (IL-1) Induces the Lys63-Linked Polyubiquitination of IL-1 Receptor-Associated Kinase 1 to Facilitate NEMO Binding and the Activation of IkappaBalpha Kinase, Mol Cell Biol, 28, 10.1128/MCB.02380-06 · DOI
  40. Gottipati, 2008, IRAK1: A Critical Signaling Mediator of Innate Immunity, Cell Signal, 20, 10.1016/j.cellsig.2007.08.009 · DOI · Paper page
  41. Conze, 2008, Lys63-Linked Polyubiquitination of IRAK-1 is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-kappaB Activation, Mol Cell Biol, 28, 10.1128/MCB.02098-07 · DOI · Paper page
  42. Lamothe, 2007, Site-Specific Lys-63-Linked Tumor Necrosis Factor Receptor-Associated Factor 6 Auto-Ubiquitination is a Critical Determinant of I Kappa B Kinase Activation, J Biol Chem, 282, 10.1074/jbc.M609503200 · DOI · Paper page
  43. Walsh, 2008, TRAF6 Autoubiquitination-Independent Activation of the Nfκb and MAPK Pathways in Response to IL-1 and RANKL, PloS One, 3, 10.1371/journal.pone.0004064 · DOI · Paper page
  44. Hu, 2017, Oligomerization-Primed Coiled-Coil Domain Interaction With Ubc13 Confers Processivity to TRAF6 Ubiquitin Ligase Activity, Nat Commun, 8, 814, 10.1038/s41467-017-01290-0 · DOI
  45. Xia, 2009, Direct Activation of Protein Kinases by Unanchored Polyubiquitin Chains, Nature, 461, 10.1038/nature08247 · DOI · Paper page
  46. Ea, 2006, Activation of IKK by TNFα Requires Site-Specific Ubiquitination of RIP1 and Polyubiquitin Binding by NEMO, Mol Cell, 22, 10.1016/j.molcel.2006.03.026 · DOI · Paper page
  47. Wu, 2006, Sensing of Lys 63-Linked Polyubiquitination by NEMO is a Key Event in NF-κB Activation, Nat Cell Biol, 8, 398, 10.1038/ncb1384 · DOI · Paper page
  48. Bhoj, 2009, Ubiquitylation in Innate and Adaptive Immunity, Nature, 458, 10.1038/nature07959 · DOI · Paper page
  49. Lo, 2009, Structural Basis for Recognition of Diubiquitins by NEMO, Mol Cell, 33, 10.1016/j.molcel.2009.01.012 · DOI · Paper page
  50. Rahighi, 2009, Specific Recognition of Linear Ubiquitin Chains by NEMO is Important for NF-kappaB Activation, Cell, 136, 10.1016/j.cell.2009.03.007 · DOI · Paper page
  51. Tokunaga, 2009, Involvement of Linear Polyubiquitylation of NEMO in NF-κb Activation, Nat Cell Biol, 11, 10.1038/ncb1821 · DOI · Paper page
  52. Fujita, 2014, Mechanism Underlying IkappaB Kinase Activation Mediated by the Linear Ubiquitin Chain Assembly Complex, Mol Cell Biol, 34, 10.1128/MCB.01538-13 · DOI
  53. Tokunaga, 2013, Linear Ubiquitination-Mediated NF-κb Regulation and its Related Disorders, J Biochem, 154, 10.1093/jb/mvt079 · DOI
  54. Noad, 2017, Randow: LUBAC-Synthesized Linear Ubiquitin Chains Restrict Cytosol-Invading Bacteria by Activating Autophagy and NF-KappaB, Nat Microbiol, 2, 17063, 10.1038/nmicrobiol.2017.63 · DOI · Paper page
  55. Shimizu, 2015, Linear Ubiquitination in Immunity, Immunol Rev, 266, 190, 10.1111/imr.12309 · DOI
  56. Sasaki, 2015, Roles of Linear Ubiquitinylation, a Crucial Regulator of NF-κb and Cell Death, in the Immune System, Immunol Rev, 266, 10.1111/imr.12308 · DOI
  57. Iwai, 2014, Linear Ubiquitin Chains: NF-κb Signalling, Cell Death and Beyond, Nat Rev Mol Cell Biol, 15, 10.1038/nrm3836 · DOI · Paper page
  58. Sato, 2005, Essential Function for the Kinase TAK1 in Innate and Adaptive Immune Responses, Nat Immunol, 6, 10.1038/ni1255 · DOI · Paper page
  59. Schuman, 2009, A Critical Role of TAK1 in B-Cell Receptor–Mediated Nuclear Factor κb Activation, Blood, 113, 10.1182/blood-2008-08-176057 · DOI
  60. Liu, 2006, Essential Role of TAK1 in Thymocyte Development and Activation, Proc Natl Acad Sci, 103, 11677, 10.1073/pnas.0603089103 · DOI
  61. Sato, 2006, TAK1 is Indispensable for Development of T Cells and Prevention of Colitis by the Generation of Regulatory T Cells, Int Immunol, 18, 10.1093/intimm/dxl082 · DOI
  62. Wan, 2006, The Kinase TAK1 Integrates Antigen and Cytokine Receptor Signaling for T Cell Development, Survival and Function, Nat Immunol, 7, 10.1038/ni1355 · DOI · Paper page
  63. Ajibade, 2012, TAK1 Negatively Regulates NF-Kappa B and P38 MAP Kinase Activation in Gr-1(+)CD11b(+) Neutrophils, Immunity, 36, 43, 10.1016/j.immuni.2011.12.010 · DOI · Paper page
  64. Lamothe, 2012, Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice, PloS One, 7, 10.1371/journal.pone.0051228 · DOI
  65. Ear, 2010, Constitutive Association of TGF-β–Activated Kinase 1 With the IκB Kinase Complex in the Nucleus and Cytoplasm of Human Neutrophils and Its Impact on Downstream Processes, J Immunol, 184, 10.4049/jimmunol.0902958 · DOI
  66. Ajibade, 2013, Cell Type-Specific Function of TAK1 in Innate Immune Signaling, Trends Immunol, 34, 10.1016/j.it.2013.03.007 · DOI · Paper page
  67. Xing, 2021, Microbiota Regulate Innate Immune Signaling and Protective Immunity Against Cancer, Cell Host Microbe, 29, 959, 10.1016/j.chom.2021.03.016 · DOI
  68. Honda, 2005, Spatiotemporal Regulation of MyD88–IRF-7 Signalling for Robust Type-I Interferon Induction, Nature, 434, 10.1038/nature03547 · DOI · Paper page
  69. Honda, 2005, IRF-7 is the Master Regulator of Type-I Interferon-Dependent Immune Responses, Nature, 434, 10.1038/nature03464 · DOI · Paper page
  70. Takaoka, 2005, Integral Role of IRF-5 in the Gene Induction Programme Activated by Toll-Like Receptors, Nature, 434, 10.1038/nature03308 · DOI · Paper page
  71. Kawai, 2008, Toll-Like Receptor and RIG-1-Like Receptor Signaling, Ann N Y Acad Sci, 1143, 1, 10.1196/annals.1443.020 · DOI · Paper page
  72. Ren, 2014, IKK Beta is an IRF5 Kinase That Instigates Inflammation, Proc Natl Acad Sci USA, 111, 10.1073/pnas.1418516111 · DOI
  73. Lopez-Pelaez, 2014, Protein Kinase IKK Beta-Catalyzed Phosphorylation of IRF5 at Ser462 Induces its Dimerization and Nuclear Translocation in Myeloid Cells, Proc Natl Acad Sci USA, 111, 10.1073/pnas.1418399111 · DOI
  74. Yamamoto, 2003, Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway, Science, 301, 10.1126/science.1087262 · DOI · Paper page
  75. Hoebe, 2003, Upregulation of Costimulatory Molecules Induced by Lipopolysaccharide and Double-Stranded RNA Occurs by Trif-Dependent and Trif-Independent Pathways, Nat Immunol, 4, 10.1038/ni1010 · DOI · Paper page
  76. Cusson-Hermance, 2005, Rip1 Mediates the Trif-Dependent Toll-Like Receptor 3- and 4-Induced NF-κB Activation But Does Not Contribute to Interferon Regulatory Factor 3 Activation*, J Biol Chem, 280, 10.1074/jbc.M506831200 · DOI · Paper page
  77. Gohda, 2004, Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway But Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling, J Immunol, 173, 2913, 10.4049/jimmunol.173.5.2913 · DOI · Paper page
  78. Chang, 2009, Peli1 Facilitates TRIF-Dependent Toll-Like Receptor Signaling and Proinflammatory Cytokine Production, Nat Immunol, 10, 10.1038/ni.1777 · DOI · Paper page
  79. McWhirter, 2004, IFN-Regulatory Factor 3-Dependent Gene Expression is Defective in Tbk1-Deficient Mouse Embryonic Fibroblasts, Proc Natl Acad Sci USA, 101, 10.1073/pnas.2237236100 · DOI · Paper page
  80. Sharma, 2003, Triggering the Interferon Antiviral Response Through an IKK-Related Pathway, Science, 300, 10.1126/science.1081315 · DOI · Paper page
  81. Fitzgerald, 2003, IKK Epsilon and TBK1 are Essential Components of the IRF3 Signaling Pathway, Nat Immunol, 4, 10.1038/ni921 · DOI · Paper page
  82. Zhao, 2016, Structural Basis for Concerted Recruitment and Activation of IRF-3 by Innate Immune Adaptor Proteins, Proc Natl Acad Sci, 113, E3403, 10.1073/pnas.1603269113 · DOI · Paper page
  83. Banchereau, 1998, Dendritic Cells and the Control of Immunity, Nature, 392, 10.1038/32588 · DOI · Paper page
  84. Schnare, 2001, Toll-Like Receptors Control Activation of Adaptive Immune Responses, Nat Immunol, 2, 10.1038/ni712 · DOI · Paper page
  85. Palliser, 2004, Myeloid Differentiation Factor 88 Is Required for Cross-Priming In Vivo, J Immunol, 172, 3415, 10.4049/jimmunol.172.6.3415 · DOI
  86. Hoshino, 2006, IκB Kinase-α is Critical for Interferon-α Production Induced by Toll-Like Receptors 7 and 9, Nature, 440, 10.1038/nature04641 · DOI · Paper page
  87. Ito, 2002, Interferon-α and Interleukin-12 Are Induced Differentially by Toll-Like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets, J Exp Med, 195, 10.1084/jem.20020207 · DOI · Paper page
  88. Reis e Sousa, 1999, The Role of Dendritic Cells in the Induction and Regulation of Immunity to Microbial Infection, Curr Opin Immunol, 11, 10.1016/S0952-7915(99)80066-1 · DOI · Paper page
  89. Nair-Gupta, 2014, TLR Signals Induce Phagosomal MHC-I Delivery From the Endosomal Recycling Compartment to Allow Cross-Presentation, Cell, 158, 10.1016/j.cell.2014.04.054 · DOI · Paper page
  90. Blander, 2006, Toll-Dependent Selection of Microbial Antigens for Presentation by Dendritic Cells, Nature, 440, 10.1038/nature04596 · DOI · Paper page
  91. Trombetta, 2003, Activation of Lysosomal Function During Dendritic Cell Maturation, Science, 299, 10.1126/science.1080106 · DOI · Paper page
  92. Turley, 2000, Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells, Science, 288, 10.1126/science.288.5465.522 · DOI · Paper page
  93. Horrevorts, 2018, Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I, Front Immunol, 9, 10.3389/fimmu.2018.01231 · DOI
  94. Sheen, 2017, TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement, J Immunol, 199, 10.4049/jimmunol.1700339 · DOI
  95. Sheng, 2013, Enhanced Dendritic Cell-Mediated Antigen-Specific CD4+ T Cell Responses: IFN-Gamma Aids TLR Stimulation, J Drug Deliv, 2013, 10.1155/2013/516749 · DOI
  96. Gao, 2012, Deficiency in TLR2 But Not in TLR4 Impairs Dendritic Cells Derived IL-10 Responses to Schistosome Antigens, Cell Immunol, 272, 10.1016/j.cellimm.2011.10.007 · DOI
  97. Guo, 2017, The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells, Front Immunol, 8, 10.3389/fimmu.2017.00158 · DOI
  98. Sharma, 2020, The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice, Front Immunol, 11, 10.3389/fimmu.2020.00171 · DOI
  99. Lombardi, 2009, Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-γ, and IL-17A by Naive CD4+ T Cells, J Immunol, 182, 10.4049/jimmunol.0801969 · DOI
  100. Dolina, 2020, TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4+ T Cells to Treg, Cell Rep, 31, 107249, 10.1016/j.celrep.2020.01.040 · DOI
  101. Mandraju, 2014, Differential Ability of Surface and Endosomal TLRs to Induce CD8 T Cell Responses In Vivo, J Immunol (Baltimore Md 1950), 192, 10.4049/jimmunol.1302244 · DOI
  102. Hornung, 2002, Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides, J Immunol, 168, 4531, 10.4049/jimmunol.168.9.4531 · DOI · Paper page
  103. Jarrossay, 2001, Specialization and Complementarity in Microbial Molecule Recognition by Human Myeloid and Plasmacytoid Dendritic Cells, Eur J Immunol, 31, 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q · DOI · Paper page
  104. Visintin, 2001, Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells, J Immunol, 166, 249, 10.4049/jimmunol.166.1.249 · DOI · Paper page
  105. Edwards, 2003, Toll-Like Receptor Expression in Murine DC Subsets: Lack of TLR7 Expression by CD8 Alpha(+) DC Correlates With Unresponsiveness to Imidazoquinolines, Eur J Immunol, 33, 10.1002/eji.200323797 · DOI · Paper page
  106. Boonstra, 2003, Flexibility of Mouse Classical and Plasmacytoid-Derived Dendritic Cells in Directing T Helper Type 1 and 2 Cell Development: Dependency on Antigen Dose and Differential Toll-Like Receptor Ligation, J Exp Med, 197, 10.1084/jem.20021908 · DOI · Paper page
  107. Anderson, 2019, Models of Dendritic Cell Development Correlate Ontogeny With Function, 10.1016/bs.ai.2019.09.001 · DOI
  108. Mills, 2011, TLR-Dependent T Cell Activation in Autoimmunity, Nat Rev Immunol, 11, 10.1038/nri3095 · DOI · Paper page
  109. Kumar, 2021, Toll-Like Receptors in Adaptive Immunity, Handb Exp Pharmacol, 225, 10.1007/164_2021_543 · DOI
  110. Wang, 2001, The Role of MHC Class II-Restricted Tumor Antigens and CD4(+) T Cells in Antitumor Immunity, Trends Immunol, 22, 10.1016/s1471-4906(01)01896-8 · DOI · Paper page
  111. Wang, 2008, Toll-Like Receptors and Immune Regulation: Implications for Cancer Therapy, Oncogene, 27, 10.1038/sj.onc.1210906 · DOI
  112. Karim, 2017, Toll Like Receptor 2 Engagement on CD4(+) T Cells Promotes TH9 Differentiation and Function, Eur J Immunol, 47, 10.1002/eji.201646846 · DOI
  113. Komai-Koma, 2004, TLR2 is Expressed on Activated T Cells as a Costimulatory Receptor, Proc Natl Acad Sci USA, 101, 10.1073/pnas.0400171101 · DOI · Paper page
  114. Imanishi, 2007, Cutting Edge: TLR2 Directly Triggers Th1 Effector Functions, J Immunol, 178, 10.4049/jimmunol.178.11.6715 · DOI · Paper page
  115. Biswas, 2009, Porin of Shigella Dysenteriae Directly Promotes Toll-Like Receptor 2-Mediated CD4(+) T Cell Survival and Effector Function, Mol Immunol, 46, 10.1016/j.molimm.2009.06.006 · DOI
  116. Sinnott, 2016, Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4(+) T Cells, J Immunol, 197, 68, 10.4049/jimmunol.1501297 · DOI
  117. Reba, 2014, TLR2 Engagement on CD4+T Cells Enhances Effector Functions and Protective Responses to Mycobacterium Tuberculosis, Eur J Immunol, 44, 10.1002/eji.201344100 · DOI
  118. Cottalorda, 2006, TLR2 Engagement on CD8 T Cells Lowers the Threshold for Optimal Antigen-Induced T Cell Activation, Eur J Immunol, 36, 10.1002/eji.200636181 · DOI · Paper page
  119. Lee, 2009, Expression and Function of TLR2 on CD4 Versus CD8 T Cells, Immune Netw, 9, 10.4110/in.2009.9.4.127 · doi:10.4110/in.2009.9.4.127
  120. Mercier, 2009, TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal, J Immunol, 182, 10.4049/jimmunol.0801167 · DOI
  121. Zhang, 2013, MyD88 Signaling in CD4 T Cells Promotes IFN-γ Production and Hematopoietic Progenitor Cell Expansion in Response to Intracellular Bacterial Infection, J Immunol (Baltimore Md 1950), 190, 10.4049/jimmunol.1203024 · DOI
  122. Xing, 2019, Host MyD88 Signaling Protects Against Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation, Clin Exp Immunol, 195, 10.1111/cei.13215 · doi:10.1111/cei.13215
  123. Satomi, 2020, Myeloid Differentiation Factor 88 Signaling in Donor T Cells Accelerates Graft-Versus-Host Disease, Haematologica, 105, 10.3324/haematol.2018.203380 · DOI
  124. Chang, 2013, MyD88 is Essential to Sustain mTOR Activation Necessary to Promote T Helper 17 Cell Proliferation by Linking IL-1 and IL-23 Signaling, Proc Natl Acad Sci USA, 110, 10.1073/pnas.1206048110 · DOI
  125. Reynolds, 2012, Toll-Like Receptor 4 Signaling in T Cells Promotes Autoimmune Inflammation, Proc Natl Acad Sci USA, 109, 10.1073/pnas.1120585109 · DOI · Paper page
  126. González-Navajas, 2010, TLR4 Signaling in Effector CD4+ T Cells Regulates TCR Activation and Experimental Colitis in Mice, J Clin Invest, 120, 10.1172/JCI40055 · DOI
  127. Zanin-Zhorov, 2007, Cutting Edge: T Cells Respond to Lipopolysaccharide Innately via TLR4 Signaling, J Immunol, 179, 41, 10.4049/jimmunol.179.1.41 · DOI
  128. Cohen, 2013, Signaling via TLR2 and TLR4 Directly Down-Regulates T Cell Effector Functions: The Regulatory Face of Danger Signals, Front Immunol, 4, 211, 10.3389/fimmu.2013.00211 · DOI
  129. Okeke, 2014, Regulatory T Cells Restrain CD4<sup<+</sup< T Cells From Causing Unregulated Immune Activation and Hypersensitivity to Lipopolysaccharide Challenge, J Immunol, 193, 655, 10.4049/jimmunol.1303064 · DOI
  130. Sahoo, 2018, VIPER Regulates Naive T Cell Activation and Effector Responses: Implication in TLR4 Associated Acute Stage T Cell Responses, Sci Rep, 8, 7118, 10.1038/s41598-018-25549-8 · DOI
  131. Qu, 2019, TLR7 Modulated T Cell Response in the Mesenteric Lymph Node of Schistosoma Japonicum-Infected C57BL/6 Mice, J Immunol Res, 2019, 10.1155/2019/2691808 · DOI
  132. Li, 2019, Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis, Front Immunol, 10, 10.3389/fimmu.2019.02191 · DOI
  133. Tabiasco, 2006, Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor, J Immunol, 177, 10.4049/jimmunol.177.12.8708 · DOI
  134. Di, 2019, Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells, Front Oncol, 9, 10.3389/fonc.2019.00241 · DOI
  135. Lai, 2018, Toll-Like Receptor 2 Costimulation Potentiates the Antitumor Efficacy of CAR T Cells, Leukemia, 32, 10.1038/leu.2017.249 · DOI
  136. George, 2020, Third-Generation Anti-CD19 Chimeric Antigen Receptor T-Cells Incorporating a TLR2 Domain for Relapsed or Refractory B-Cell Lymphoma: A Phase I Clinical Trial Protocol (ENABLE), BMJ Open, 10, 10.1136/bmjopen-2019-034629 · DOI
  137. Vignali, 2008, How Regulatory T Cells Work, Nat Rev Immunol, 8, 10.1038/nri2343 · DOI · Paper page
  138. Walker, 2003, Induction of FoxP3 and Acquisition of T Regulatory Activity by Stimulated Human CD4(+)CD25(-) T Cells, J Clin Invest, 112, 10.1172/jci200319441 · DOI
  139. Khattri, 2003, An Essential Role for Scurfin in CD4(+)CD25(+) T Regulatory Cells, Nat Immunol, 4, 10.1038/ni909 · DOI · Paper page
  140. Wang, 2004, Tumor-Specific Human CD4(+) Regulatory T Cells and Their Ligands: Implications for Immunotherapy, Immunity, 20, 10.1016/s1074-7613(03)00359-5 · DOI · Paper page
  141. Liyanage, 2002, Prevalence of Regulatory T Cells is Increased in Peripheral Blood and Tumor Microenvironment of Patients With Pancreas or Breast Adenocarcinoma, J Immunol, 169, 10.4049/jimmunol.169.5.2756 · DOI · Paper page
  142. Woo, 2001, Regulatory CD4(+)CD25(+) T Cells in Tumors From Patients With Early-Stage non-Small Cell Lung Cancer and Late-Stage Ovarian Cancer, Cancer Res, 61
  143. Wang, 2005, Recognition of a New ARTC1 Peptide Ligand Uniquely Expressed in Tumor Cells by Antigen-Specific CD4(+) Regulatory T Cells, J Immunol, 174, 10.4049/jimmunol.174.5.2661 · DOI
  144. Wang, 2007, Regulatory T Cells and Cancer, Curr Opin Immunol, 19, 10.1016/j.coi.2007.02.004 · DOI · Paper page
  145. Peng, 2007, Tumor-Infiltrating Gamma Delta T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-Like Receptor Signaling Pathway, Immunity, 27, 10.1016/j.immuni.2007.05.020 · DOI · Paper page
  146. Kiniwa, 2007, CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer, Clin Cancer Res, 13, 10.1158/1078-0432.ccr-07-0842 · DOI · Paper page
  147. Peng, 2005, Toll-Like, Receptor 8-Mediated Reversal of CD4(+) Regulatory T Cell Function, Science, 309, 10.1126/science.1113401 · DOI · Paper page
  148. Heil, 2004, Species-Specific Recognition of Single-Stranded RNA via Toll-Like Receptor 7 and 8, Science, 303, 10.1126/science.1093620 · DOI · Paper page
  149. Li, 2019, TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy, Cell Metab, 29, 103, 10.1016/j.cmet.2018.09.020 · DOI · Paper page
  150. Shang, 2020, Ovarian Cancer Cells Promote Glycolysis Metabolism and TLR8-Mediated Metabolic Control of Human CD4+ T Cells, Front Oncol, 10, 10.3389/fonc.2020.570899 · DOI
  151. Jurk, 2002, Human TLR7 or TLR8 Independently Confer Responsiveness to the Antiviral Compound R-848, Nat Immunol, 3, 10.1038/ni0602-499 · DOI · Paper page
  152. Netea, 2004, Toll-Like Receptor 2 Suppresses Immunity Against Candida Albicans Through Induction of IL-10 and Regulatory T Cells, J Immunol, 172, 10.4049/jimmunol.172.6.3712 · DOI · Paper page
  153. Sutmuller, 2006, Toll-Like Receptor 2 Controls Expansion and Function of Regulatory T Cells, J Clin Invest, 116, 10.1172/jci25439 · DOI · Paper page
  154. Liu, 2006, Toll-Like Receptor 2 Signaling Modulates the Functions of CD4+ CD25+ Regulatory T Cells, Proc Natl Acad Sci USA, 103, 10.1073/pnas.0601554103 · DOI · Paper page
  155. LaRosa, 2007, CpG DNA Inhibits CD4+CD25+ Treg Suppression Through Direct MyD88-Dependent Costimulation of Effector CD4+ T Cells, Immunol Lett, 108, 10.1016/j.imlet.2006.12.007 · DOI
  156. Urry, 2009, Ligation of TLR9 Induced on Human IL-10-Secreting Tregs by 1alpha,25-Dihydroxyvitamin D3 Abrogates Regulatory Function, J Clin Invest, 119, 10.1172/JCI32354 · DOI · Paper page
  157. Crellin, 2005, Human CD4(+) T Cells Express TLR5 and its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4(+)CD25(+) T Regulatory Cells, J Immunol, 175, 10.4049/jimmunol.175.12.8051 · DOI · Paper page
  158. Caramalho, 2003, Regulatory T Cells Selectively Express Toll-Like Receptors and are Activated by Lipopolysaccharide, J Exp Med, 197, 10.1084/jem.20021633 · DOI · Paper page
  159. Cui, 2014, Mechanisms and Pathways of Innate Immune Activation and Regulation in Health and Cancer, Hum Vaccines Immunother, 10, 10.4161/21645515.2014.979640 · DOI · Paper page
  160. Baumann, 2010, CD14 is a Coreceptor of Toll-Like Receptors 7 and 9, J Exp Med, 207, 10.1084/jem.20101111 · DOI · Paper page
  161. LeBouder, 2003, Soluble Forms of Toll-Like Receptor (TLR)2 Capable of Modulating TLR2 Signaling are Present in Human Plasma and Breast Milk, J Immunol, 171, 10.4049/jimmunol.171.12.6680 · DOI · Paper page
  162. Iwami, 2000, Cutting Edge: Naturally Occurring Soluble Form of Mouse Toll-Like Receptor 4 Inhibits Lipopolysaccharide Signaling, J Immunol, 165, 10.4049/jimmunol.165.12.6682 · DOI · Paper page
  163. Brint, 2004, ST2 is an Inhibitor of Interleukin 1 Receptor and Toll-Like Receptor 4 Signaling and Maintains Endotoxin Tolerance, Nat Immunol, 5, 10.1038/ni1050 · DOI · Paper page
  164. Garlanda, 2004, Intestinal Inflammation in Mice Deficient in Tir8, an Inhibitory Member of the IL-1 Receptor Family, Proc Natl Acad Sci USA, 101, 10.1073/pnas.0308680101 · DOI · Paper page
  165. Wald, 2003, SIGIRR, a Negative Regulator of Toll-Like Receptor-Interleukin 1 Receptor Signaling, Nat Immunol, 4, 10.1038/ni968 · DOI · Paper page
  166. Diehl, 2004, TRAIL-R as a Negative Regulator of Innate Immune Cell Responses, Immunity, 21, 10.1016/j.immuni.2004.11.008 · DOI · Paper page
  167. Nakagawa, 2002, SOCS-1 Participates in Negative Regulation of LPS Responses, Immunity, 17, 10.1016/s1074-7613(02)00449-1 · DOI · Paper page
  168. Burns, 2003, Inhibition of Interleukin 1 Receptor/Toll-Like Receptor Signaling Through the Alternatively Spliced, Short Form of MyD88 is Due to its Failure to Recruit IRAK-4, J Exp Med, 197, 10.1084/jem.20021790 · DOI · Paper page
  169. Janssens, 2002, Regulation of Interleukin-1-and Lipopolysaccharide-Induced NF-Kappa B Activation by Alternative Splicing of Myd88, Curr Biol, 12, 10.1016/s0960-9822(02)00712-1 · DOI · Paper page
  170. Zhang, 2002, Negative Regulation of Toll-Like Receptor-Mediated Signaling by Tollip, J Biol Chem, 277, 10.1074/jbc.M109537200 · DOI · Paper page
  171. Kobayashi, 2002, IRAK-M is a Negative Regulator of Toll-Like Receptor Signaling, Cell, 110, 191, 10.1016/s0092-8674(02)00827-9 · DOI · Paper page
  172. Shembade, 2010, Inhibition of NF-Kappa B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes, Science, 327, 10.1126/science.1182364 · DOI · Paper page
  173. Boone, 2004, The Ubiquitin-Modifying Enzyme A20 is Required for Termination of Toll-Like Receptor Responses, Nat Immunol, 5, 10.1038/ni1110 · DOI · Paper page
  174. Lee, 2010, Regulation of Natural Killer T-Cell Development by Deubiquitinase CYLD, EMBO J, 29, 10.1038/emboj.2010.31 · DOI
  175. Reiley, 2007, Deubiquitinating Enzyme CYLD Negatively Regulates the Ubiquitin-Dependent Kinase Tak1 and Prevents Abnormal T Cell Responses, J Exp Med, 204, 10.1084/jem.20062694 · DOI · Paper page
  176. Reiley, 2006, Regulation of T Cell Development by the Deubiquitinating Enzyme CYLD, Nat Immunol, 7, 10.1038/ni1315 · DOI · Paper page
  177. Trompouki, 2003, CYLD Is a Deubiquitinating Enzyme That Negatively Regulates NF-Kappa B Activation by TNFR Family Members, Nature, 424, 10.1038/nature01803 · DOI · Paper page
  178. Kovalenko, 2003, The Tumour Suppressor CYLD Negatively Regulates NF-Kappa B Signalling by Deubiquitination, Nature, 424, 10.1038/nature01802 · DOI · Paper page
  179. Tong, 2012, Enhanced TLR-Induced NF-Kappa B Signaling and Type I Interferon Responses in NLRC5 Deficient Mice, Cell Res, 22, 10.1038/cr.2012.53 · DOI
  180. Schneider, 2012, The Innate Immune Sensor NLRC3 Attenuates Toll-Like Receptor Signaling via Modification of the Signaling Adaptor TRAF6 and Transcription Factor NF-Kappa B, Nat Immunol, 13, 10.1038/ni.2378 · DOI · Paper page
  181. Anand, 2012, NLRP6 Negatively Regulates Innate Immunity and Host Defence Against Bacterial Pathogens, Nature, 488, 10.1038/nature11250 · DOI · Paper page
  182. Xia, 2011, NLRX1 Negatively Regulates TLR-Induced NF-Kappa B Signaling by Targeting TRAF6 and IKK, Immunity, 34, 10.1016/j.immuni.2011.02.022 · DOI · Paper page
  183. Kumar, 2011, NLRC5 Deficiency Does Not Influence Cytokine Induction by Virus and Bacteria Infections, J Immunol, 186, 994, 10.4049/jimmunol.1002094 · DOI
  184. Allen, 2011, NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering With the RIG-I-MAVS and TRAF6-NF-Kappa B Signaling Pathways, Immunity, 34, 10.1016/j.immuni.2011.03.026 · DOI · Paper page
  185. Cui, 2010, NLRC5 Negatively Regulates the NF-Kappa B and Type I Interferon Signaling Pathways, Cell, 141, 10.1016/j.cell.2010.03.040 · DOI · Paper page
  186. Benko, 2010, NLRC5 Limits the Activation of Inflammatory Pathways, J Immunol, 185, 10.4049/jimmunol.0903900 · DOI · Paper page
  187. Tattoli, 2008, NLRX1 is a Mitochondrial NOD-Like Receptor That Amplifies NF-Kappa B and JNK Pathways by Inducing Reactive Oxygen Species Production, EMBO Rep, 9, 293, 10.1038/sj.embor.7401161 · DOI · Paper page
  188. Wu, 2017, NLRP11 Attenuates Toll-Like Receptor Signalling by Targeting TRAF6 for Degradation via the Ubiquitin Ligase RNF19A, Nat Commun, 8, 10.1038/s41467-017-02073-3 · DOI
  189. Meng, 2015, Reversible Ubiquitination Shapes NLRC5 Function and Modulates NF-κb Activation Switch, J Cell Biol, 211, 10.1083/jcb.201505091 · DOI
  190. Shi, 2008, TRIM30 Alpha Negatively Regulates TLR-Mediated NF-Kappa B Activation by Targeting TAB2 and TAB3 for Degradation, Nat Immunol, 9, 10.1038/ni1577 · DOI · Paper page
  191. Moore, 2008, NLRX1 is a Regulator of Mitochondrial Antiviral Immunity, Nature, 451, 10.1038/nature06501 · DOI · Paper page
  192. Kobayashi, 2012, NLRC5: A Key Regulator of MHC Class I-Dependent Immune Responses, Nat Rev Immunol, 12, 10.1038/nri3339 · DOI · Paper page
  193. Feng, 2017, LRRC25 Functions as an Inhibitor of NF-κb Signaling Pathway by Promoting P65/RelA for Autophagic Degradation, Sci Rep, 7, 10.1038/s41598-017-12573-3 · DOI
  194. Du, 2018, LRRC25 Inhibits Type I IFN Signaling by Targeting ISG15-Associated RIG-I for Autophagic Degradation, EMBO J, 37, 10.15252/embj.201796781 · DOI · Paper page
  195. Zhao, 2020, USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation, Adv Sci (Weinheim Baden-Wurttemberg Germany), 7, 2002680, 10.1002/advs.202002680 · DOI
  196. Lin, 2016, USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination Through NLRP4 Signalosome, Mol Cell, 64, 10.1016/j.molcel.2016.08.029 · DOI
  197. Chen, 2016, TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor P62 to Promote Innate Immune Responses, Mol Cell, 64, 10.1016/j.molcel.2016.08.025 · DOI · Paper page
  198. Chen, 2019, TRIM14 Promotes Noncanonical NF-κb Activation by Modulating P100/P52 Stability via Selective Autophagy, Adv Sci (Weinheim Baden-Wurttemberg Germany), 7, 1901261, 10.1002/advs.201901261 · DOI
  199. Tan, 2017, Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling, Mol Cell, 68, 293, 10.1016/j.molcel.2017.09.035 · DOI
  200. Zhou, 2014, TRIM14 is a Mitochondrial Adaptor That Facilitates Retinoic Acid-Inducible Gene-I–like Receptor-Mediated Innate Immune Response, Proc Natl Acad Sci, 111, 10.1073/pnas.1316941111 · DOI

200 of 313 shown

Cited by

See all 972

Metadata

Authors
Duan, T., Du, Y., Xing, C., Wang, H. Y., & Wang, R.-F.
Venue
Frontiers in Immunology
Published
2022-03-03
Volume
13
Pages
812774-812774
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4214925106
Cited by
972
References
21
FWCI
55.74
Type
journal article
Language
en
Open access
gold
Funders
  • National Institutes of Health (R01CA101795, R01CA246547)
  • National Cancer Institute (U54CA210181)
  • U.S. Department of Defense (BC151081, LC200368)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. https://app.cochat.ai/papers/10.3389/fimmu.2022.812774
The paper
Duan, T., Du, Y., Xing, C., Wang, H. Y., & Wang, R.-F. (2022). Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.812774

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.